| Role |
Name |
Disclosure |
Details |
| Author | KoKo Aung, MD, MPH, FACP, Assistant Professor, Department of Medicine, University of Texas Health Science Center | Nothing to disclose | Details | | Coauthor | Magdi Salmon, MD, Consulting Staff, Department of Internal Medicine, St Joseph's Hospital Services of Rhode Island | Nothing to disclose | Details | | Medical Editor | Robert A Gabbay, MD, PhD, Associate Professor of Medicine, Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, Director, Penn State Diabetes Center, Hershey Medical Center, Pennsylvania State University College of Medicine | Pfizer, Novo Nordisk, Merck | Details | | Pharmacy Editor | Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine | Nothing to disclose | Details | | Managing Editor | Arthur B Chausmer, MD, PhD, FACP, FACE, FACN, CNS, Affiliate Research Professor, School of Computational Sciences; Principal, Bioinformatics and Computational Biology Program, C/A Informatics, LLC | Nothing to disclose | Details | | CME Editor | Mark Cooper, MBBS, PhD, FRACP, Head, Diabetes & Metabolism Division, Baker Heart Research Institute, Professor of Medicine, Monash University | Nothing to disclose | Details | | Chief Editor | George T Griffing, MD, Professor of Medicine, Director of General Internal Medicine, St Louis University | Nothing to disclose | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Magdi Salmon, Coauthor |
The contributor discloses no conflict of interest. |
|